Kingworld Medicines Group (HKSE:01110) Other Current Receivables: HK$50.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01110 Kingworld Medicines Group Ltd HKSE:01110
47 GF Score
Price HK$0.42
GF Value HK$0.50
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Kingworld Medicines Group Other Current Receivables?

Kingworld Medicines Group HKSE:01110 +3.70% 47 Other Current Receivables is HK$50.6 Mil as of Dec. 2025. GuruFocus rates HKSE:01110 with a GF Score™ of 47/100 and a GF Value™ of HK$0.50 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Kingworld Medicines Group's Other Current Receivables for the quarter that ended in Dec. 2025 was HK$50.6 Mil.

Kingworld Medicines Group's quarterly Other Current Receivables declined from Dec. 2024 (HK$84.37 Mil) to Jun. 2025 (HK$30.89 Mil) but then increased from Jun. 2025 (HK$30.89 Mil) to Dec. 2025 (HK$50.63 Mil).

Kingworld Medicines Group's annual Other Current Receivables declined from Dec. 2023 (HK$145.85 Mil) to Dec. 2024 (HK$84.37 Mil) and declined from Dec. 2024 (HK$84.37 Mil) to Dec. 2025 (HK$50.63 Mil).

Kingworld Medicines Group Other Current Receivables Related Terms

Kingworld Medicines Group Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Kingworld Medicines Group's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kingworld Medicines Group Other Current Receivables Chart

Kingworld Medicines Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 175.87 182.86 145.85 84.37 50.63

Kingworld Medicines Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125.88 84.37 30.89 50.63 57.44
HKSE:01110
47GF Score
Kingworld Medicines Group Ltd HKSE:01110
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kingworld Medicines Group Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of HK$50.6 Mil mean?
Kingworld Medicines Group (HKSE:01110) has a Other Current Receivables of HK$50.6 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Kingworld Medicines Group and its competitors.
Is Kingworld Medicines Group's Other Current Receivables too high?
Kingworld Medicines Group's current Other Current Receivables is HK$50.6 Mil. Overall, Kingworld Medicines Group has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kingworld Medicines Group's Other Current Receivables compare to competitors?
Kingworld Medicines Group's Other Current Receivables of HK$50.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Kingworld Medicines Group and its competitors. Kingworld Medicines Group's current Other Current Receivables is HK$50.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kingworld Medicines Group stock overvalued right now?
Based on GuruFocus' analysis, Kingworld Medicines Group (HKSE:01110) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.50, compared to a current price of HK$0.42 — trading 16% below its estimated fair value. The current Other Current Receivables is HK$50.6 Mil. Kingworld Medicines Group's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Kingworld Medicines Group (HKSE:01110), the current Other Current Receivables is HK$50.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kingworld Medicines Group (HKSE:01110) Overvalued in 2026?

Based on GuruFocus' analysis, Kingworld Medicines Group stock appears to be undervalued. The current stock price of HK$0.42 is trading 16% below its estimated GF Value™ of HK$0.50. GuruFocus considers Kingworld Medicines Group to be Modestly Undervalued.

Key valuation signals for HKSE:01110:

  • Other Current Receivables: HK$50.6 Mil
  • GF Value™: HK$0.50 vs. price of HK$0.42 (16% below fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kingworld Medicines Group Business Description

Address 198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in the Distribution of pharmaceutical and healthcare products, such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from the Distribution sales of the pharmaceutical and healthcare products segment.
47GF Score

Get the complete analysis for HKSE:01110

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.42
Price
HK$0.50
GF Value